May 1st 2025
The Inflation Reduction Act's (IRAs) drug negotiation provisions will fundamentally reshape Medicare drug pricing, provider reimbursement, and healthcare delivery dynamics across Part B and commercial markets, according to panelists at Asembia’s AXS25 Summit.
HHS Guidance Requires Specialty Pharmacies to Scrutinize Patient Cost-Sharing and Incentive Programs
February 14th 2017Specialty pharmacies will need to carefully consider the effect of the final rule regarding Anti-Kickback Statute safe harbors and Civil Monetary Penalty Law exceptions on their existing patient benefit programs.
Patient Management in the New Era of Specialty Pharmacy
November 15th 2016Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty stakeholders will need to alter current patient management programs as new drugs transform the treatment of diseases into more manageable conditions.